ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

POLX Polarean Imaging Plc

3.65
-0.10 (-2.67%)
Last Updated: 08:45:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.67% 3.65 3.50 3.80 3.75 3.65 3.75 52,736 08:45:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.58 8.09M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 3.75p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.65p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £8.09 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.58.

Polarean Imaging Share Discussion Threads

Showing 6451 to 6473 of 6500 messages
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older
DateSubjectAuthorDiscuss
10/4/2024
11:30
Funded to Oct 2024. Assured finance in place and detailed. European market partner incoming . Deals pending. But wait nigel knows more or can't read
moontheloon
10/4/2024
11:24
It's burning c.$800k a month with very little revenue. That is unsustainable.
nigelpm
10/4/2024
11:19
Something big due you either miss it or you get it. Just do your own deep research
moontheloon
10/4/2024
11:18
Well fda approval it went down work that out . Codes went down. Undervalued. Be a good scenario for current buyers
moontheloon
10/4/2024
10:48
We've been close to all sorts of things here for years - guess what - none of it to date has added any value to the business
nigelpm
10/4/2024
10:34
Yawn. Duke is being financed as we speak. Don't let the depressed share price caused by the amati departure cloud your judgment. If you don't like them leave. Go elsewhere ffs
moontheloon
10/4/2024
10:04
No Board should have wasted £27million like this.

The current CEO and Chairman and Board of directors are receiving top rate
salaries and directors fees.

They refuse to hold an investor meeting or any UK AGM where shareholders can raise their hand to vote.

They refused to answer questions shortly after FDA approval and only repeated versions of the presentation and disabled questions on the day.

It is long overdue that Mr Driehuys delivered his own university from research to clinical.
This is no longer a research project

goldbutler
10/4/2024
10:03
Polarean technology may be first class but UK investors responsible
for financing it to this stage have had no return from it.

The CEO only refers to two shareholder groups.

Why have they left fund raise until now - are they running down the clock to the last two minutes- is it a shakedown.

goldbutler
10/4/2024
10:02
Amaretto1 notice the common theme R Griffiths
john henry
10/4/2024
09:47
This is isn't going that way believe me. Keep an eye on Recent links on LinkedIn things occurring .. think we are close to a European partner and part of the funding scenario. I've had dialogue with certain people in my research. Make of that what you will. Believe or not. I'm happy to hold and add.
moontheloon
10/4/2024
08:29
ETX another de listing
amaretto1
09/4/2024
14:57
https://www.linkedin.com/posts/polarean-inc-_cluster-analysis-to-identify-long-covid-phenotypes-activity-7183456135029346306-Ooiw?utm_source=share&utm_medium=member_android
moontheloon
08/4/2024
08:16
Convert all trialists who have it already and love it... sometimes 2 times ;) in the next two years we have a profitable foundation. An high level de novo and one of the very top institutions in the u s came from nowhere... add these on top. Gas exchange on its way and a game changer and code enlargement for children. And potentially private health plans as these have started being put through as a precedence. I'm talking from a researched position.. parasites are exactly that, they just try to scare old grannies. Pathetic humans really. Sad.
moontheloon
08/4/2024
08:07
Sure a few other isas etc will be being topped up in the coming week.
moontheloon
08/4/2024
08:05
In for few more. Wink wink
moontheloon
08/4/2024
07:48
They have 3 paid for sites functioning producing scans, target 5-7 2024. Two more. Duke is 100% in the bag I know I've researched deeply. Md Anderson top man stated also can't wait for it. Other triallists know its array of benefits and no radioactive improvements on traditional mri... as do Philips. Resulting in the great benefits for institutions and patients of being able to assess regular the state of the Lungs which radiation restricts. Go and find a company you like I would say. Thata a good fella
moontheloon
07/4/2024
17:56
They need to generate a lot of revenue. I said back late last year time was ticking and they needed a lot of commercial traction early in 2024 - it hasn't happened.
nigelpm
07/4/2024
17:30
Ummm.errrrr…Moontheloon. Yes big rebound due IF they can generate revenue. Big IF.
purchaseatthetop
07/4/2024
16:42
Doesn't matter whether it's listed or not - it's still pretty much game over.
nigelpm
07/4/2024
16:42
Need a bug spray rns for the case of parasites we seem to have. Sp irrelevant when not selling
moontheloon
07/4/2024
16:40
Gla lth. Plenty to come. Big rebound due.
moontheloon
07/4/2024
16:39
Trying your sweet best now butler. I'll be honest it's way off and getting really boring now. Yawn. Find yourself a company you might actually buy shares in. You're boring holders here
moontheloon
07/4/2024
14:01
It is curious GregB and DYMTurbo that theBoard of Directors has refused to do it.
Amaretto1 has a word for it.
It appears that the new CEO and Board are only interested in Bracco and Nukem
They seek finance via AIM. They cannot bring themselves to refer to shareholders.
The previous Chairman Mr Allis did
On behalf of the Board, I thank the employees, stakeholders and shareholders for their support, without which none of this would have been possible.

goldbutler
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older

Your Recent History

Delayed Upgrade Clock